Clinical characteristics
| Cisapride (n=18) | Placebo (n=16) | |
|---|---|---|
| Birth weight (g) | 1299 (290) | 1174 (363) |
| Gestation (weeks) | 28.8 (1.9) | 28.4 (2.1) |
| Male | 12 (67) | 10 (63) |
| Hyaline membrane disease | 9 (50) | 8 (50) |
| 5 min Apgar | 8.0 (0.9) | 7.7 (1.2) |
| Mechanical ventilation | 12 (67) | 14 (88) |
| PDA | 2 (11) | 3 (19) |
| Indomethacin | 2 (11) | 3 (19) |
| Theophylline | 15 (83) | 15 (94) |
| UAC | 6 (33) | 5 (31) |
| Breast milk | 17 (94) | 14 (88) |
| Age at trial start (days) | ||
| Median (range) | 4.0 (1-12) | 4.0 (1-17) |
Mean (SD) are shown. UAC: unbilical arterial catheter. Percentages are shown in paretheses.